Hikma Pharmaceuticals PLC (LON:HIK)
1,594.00
+4.00 (0.25%)
At close: Dec 5, 2025
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of December 31, 2024. The number of employees increased by 400 or 4.40% compared to the previous year.
Employees
9,500
Change (1Y)
400
Growth (1Y)
4.40%
Revenue / Employee
247.09K GBP
Profits / Employee
28.50K GBP
Market Cap
3.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,382 |
Hikma Pharmaceuticals News
- 27 days ago - Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript - Seeking Alpha
- 2 months ago - FTSE 100 hits another high despite concerns over US government shutdown - Evening Standard
- 4 months ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript - Seeking Alpha
- 4 months ago - Hikma Pharmaceuticals PLC 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript - Seeking Alpha
- 4 months ago - Hikma Pharmaceuticals tumbles after injectables margin outlook cut - Reuters
- 4 months ago - Hikma Pharmaceuticals: a quality compounder waiting for a catalyst - The Armchair Trader
- 5 months ago - Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - PRNewsWire